#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4841107	ADME	Half life in Sprague-Dawley rat at 10 mg/kg, po measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
2.	ALA4841108	ADME	Half life in Sprague-Dawley rat at 3 mg/kg, iv measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	4	ALA4840327	organism-based format	Scientific Literature
3.	ALA4841109	ADME	Metabolic stability in ICR mouse liver microsomes assessed as parent compound remaining at 0.1 uM incubated for 60 mins in presence of NADPH by LC-MS/MS analysis	Mus musculus	6	ALA4840327	microsome format	Scientific Literature
4.	ALA4841110	ADME	Metabolic stability in Sprague-Dawley rat plasma assessed as parent compound remaining at 1 uM incubated for 120 mins by LC-MS/MS analysis	Rattus norvegicus	6	ALA4840327	cell-free format	Scientific Literature
5.	ALA4841113	Binding	Inhibition of human recombinant DPP9 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay	Homo sapiens	18	ALA4840327	single protein format	Scientific Literature
6.	ALA4841114	ADME	Cytotoxicity against human L02 cells assessed as cell viability up to 100 uM measured after 48 hrs by MTT assay relative to control	Homo sapiens	5	ALA4840327	cell-based format	Scientific Literature
7.	ALA4841115	Binding	Inhibition of human recombinant DPP8 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay	Homo sapiens	18	ALA4840327	single protein format	Scientific Literature
8.	ALA4841116	Binding	Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay	Homo sapiens	36	ALA4840327	single protein format	Scientific Literature
9.	ALA4841121	ADME	Cmax in Sprague-Dawley rat at 3 mg/kg, iv measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	4	ALA4840327	organism-based format	Scientific Literature
10.	ALA4841122	ADME	Cmax in Sprague-Dawley rat at 10 mg/kg, po measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
11.	ALA4841123	ADME	AUC (0 to infinity) in Sprague-Dawley rat at 3 mg/kg, iv measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	4	ALA4840327	organism-based format	Scientific Literature
12.	ALA4841124	ADME	AUC (0 to infinity) in Sprague-Dawley rat at 10 mg/kg, po measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
13.	ALA4841125	ADME	Clearance in Sprague-Dawley rat at 3 mg/kg, iv measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	4	ALA4840327	organism-based format	Scientific Literature
14.	ALA4841126	ADME	Clearance in Sprague-Dawley rat at 10 mg/kg, po measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
15.	ALA4841127	ADME	Oral bioavailability in Sprague-Dawley rat at 10 mg/kg measured after 48 hrs by LC-MS/MS analysis	Rattus norvegicus	1	ALA4840327	organism-based format	Scientific Literature
16.	ALA4841128	Functional	In vivo inhibition of DPP4 in Sprague-Dawley rat plasma at 10 mg/kg, po via gavage using Gly-Pro-AMC as substrate measured after 30 mins relative to control	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
17.	ALA4841129	Functional	In vivo inhibition of DPP4 in Sprague-Dawley rat plasma at 10 mg/kg, po via gavage using Gly-Pro-AMC as substrate measured after 12 hrs relative to control	Rattus norvegicus	3	ALA4840327	organism-based format	Scientific Literature
18.	ALA4841130	Functional	In vivo inhibition of DPP4 in Sprague-Dawley rat plasma at 10 mg/kg, po via gavage using Gly-Pro-AMC as substrate measured after 24 hrs relative to control	Rattus norvegicus	2	ALA4840327	organism-based format	Scientific Literature
19.	ALA4841131	Functional	Hypoglycemic activity in ICR mouse assessed as reduction in glucose secretion at 10 mg/kg, po via gavage administered as single dose pretreated with compound followed by glucose challenge measured after 120 mins relative to control	Mus musculus	2	ALA4840327	organism-based format	Scientific Literature
20.	ALA4841132	Functional	Hypoglycemic activity in po dosed overnight fasted C57BL/6 db/db mouse assessed as improvement in glucose tolerance pretreated with compound for 30 mins followed by oral glucose challenge and measured up to 120 mins by glucometer	Mus musculus	1	ALA4840327	organism-based format	Scientific Literature